First human tests begin for mysterious new drug
NCT ID NCT07222254
Summary
This early-stage study aims to check if a new experimental drug called AZD0292 is safe for people and how the body processes it. The trial involves 18 healthy Japanese volunteers who will receive either the drug or a placebo through an IV. Researchers will monitor participants closely for side effects and measure how the drug moves through their bodies over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Sumida-ku, 130-0004, Japan
Conditions
Explore the condition pages connected to this study.